November 2026

AI in Brief — Sunday, 22 November 2026

Anthropic, the AI safety company, went public on the Nasdaq this week in an initial public offering that broke records but faced a rocky first full day of trading as markets plunged on concerns about artificial intelligence spending. Source United Nations diplomats meeting in Geneva this week failed to agree on rules regulating autonomous weapons,

AI in Brief — Sunday, 22 November 2026 Read More »

AI in Brief — Saturday, 21 November 2026

Levent Alpöge, a mathematician at Anthropic, claims to have proved the Riemann hypothesis with the help of Claude, the company's AI assistant. The Riemann hypothesis is one of mathematics's most prestigious unsolved problems and one of the Clay Mathematics Institute's Millennium Prize problems. If verified, the proof would mark a major achievement for AI in

AI in Brief — Saturday, 21 November 2026 Read More »

AI in Brief — Thursday, 19 November 2026

Anthropic priced its initial public offering at $83 per share, above its projected range, valuing the AI safety company at $1.5 trillion on a fully diluted basis. The offering marks a significant milestone for the OpenAI competitor, which has developed Claude, a rival large language model. Source Humyn Labs, an Indian data-labeling startup founded in

AI in Brief — Thursday, 19 November 2026 Read More »

AI in Brief — Wednesday, 18 November 2026

Isomorphic Labs, the AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round as it prepares to advance drug candidates into clinical trials. The capital injection underscores growing investor confidence in AI-driven pharmaceutical development, with Isomorphic now positioned to move beyond computational drug discovery into

AI in Brief — Wednesday, 18 November 2026 Read More »

Cookie Consent with Real Cookie Banner